A newly published study has sparked discussion in the medical community by identifying an unexpected link between current smoking and a lower risk of Parkinson disease. While smoking is widely known to cause severe health problems, researchers found that people who currently smoke may have a lower likelihood of developing Parkinson disease compared to those who quit.
This article reviews the findings, explains what they mean for public health, and clarifies why quitting smoking remains essential despite the results.
The study, published online on February 25, 2026 in the journal American Academy of Neurology’s journal Neurology, examined how changes in smoking behavior over time affect the risk of Parkinson disease and overall mortality.
Researchers led by Sung-Ho Ahn from Yonsei University College of Medicine in Seoul, South Korea conducted a large retrospective cohort study. The research team analyzed health data from 410,489 adults aged 40 years and older. Participants were divided into four groups:
The median follow up period was 9.1 years.
The most striking result was that persistent smokers had the lowest risk of developing Parkinson disease during the study period.
Compared with persistent smokers:
However, when researchers examined overall mortality, the findings changed direction:
This means that although persistent smokers showed lower Parkinson disease incidence, they did not experience lower overall mortality.
Parkinson disease is a progressive neurological disorder that affects movement. It develops when dopamine producing neurons in the brain gradually deteriorate. Common symptoms include:
Parkinson disease typically affects adults over the age of 60, though early onset cases can occur. The exact cause remains unclear, but genetic and environmental factors are believed to contribute.
Researchers emphasized that the association does not mean smoking is protective in a healthy way. Instead, scientists suspect certain components of tobacco smoke may influence neurological pathways.
One theory involves nicotine. Nicotine interacts with dopamine systems in the brain, which are central to Parkinson disease pathology. It is possible that nicotine temporarily alters neurochemical activity in a way that reduces observable disease risk.
Coauthor Jun Hyuk Lee from Eulji University School of Medicine stated that the reduced risk appears linked to current smoking status rather than the total duration of smoking. This suggests that biological effects may depend on active exposure.
However, the study does not prove that smoking prevents Parkinson disease. It only identifies an association.
Despite the findings, medical experts strongly caution against interpreting the results as a reason to smoke.
Smoking is a well established cause of:
The study clearly showed that people who quit smoking had lower all cause mortality. Sustained quitters experienced the greatest survival benefit.
In other words, quitting smoking improves overall longevity even if Parkinson disease risk patterns differ.
One important concept in medical research is the difference between association and causation.
An association means two factors occur together more often than expected by chance. It does not prove that one causes the other.
There are several possible explanations for the results:
Further research is needed to clarify these mechanisms.
Researchers suggested that identifying which components of smoking influence Parkinson risk could lead to new therapies.
If nicotine or another compound has neuroprotective effects, scientists may be able to develop targeted medications that replicate those benefits without exposing patients to the toxic chemicals found in tobacco smoke.
Such an approach would aim to separate potential neurological effects from the harmful cardiovascular and cancer related consequences of smoking.
From a public health perspective, the message remains clear: quitting smoking saves lives.
Although the study observed lower Parkinson incidence among persistent smokers, the mortality data reinforces decades of evidence showing that smoking increases overall health risks.
Healthcare professionals encourage:
Modern cessation strategies continue to evolve, including digital tools and smartphone applications that support behavior change.
The link between smoking and Parkinson disease has been observed in earlier studies. Researchers have consistently reported lower rates of Parkinson disease among current smokers compared to nonsmokers.
However, this paradox has never outweighed the overwhelming evidence of smoking related harm.
The current study adds nuance by examining changes in smoking behavior over time rather than simply comparing smokers to nonsmokers.
Gotkine E. Study Shows Association Between Current Smoking and Lower Risk for Parkinson Disease. Neurology on February 25, 2026.
This article summarizes medical research findings for informational and educational purposes only. Statistical data reflect general population trends and do not apply to individual cases. Individual health risks vary widely based on genetics, lifestyle, and medical history. This content is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider regarding personal health decisions, including smoking cessation or concerns about Parkinson disease.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.